{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:49:28Z","timestamp":1791460168041,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The World Health Organization (WHO) recommends Mass Drug Administration (MDA) to reduce malaria transmission in low-transmission settings, with a target coverage of at least 80%. To maximize impact, the development of effective and sustainable programmatic implementation strategies is essential. Between December 2022 and February 2023, two rounds of programmatic MDA (pMDA) were implemented in Chidenguele, in Gaza province, Mozambique. The target population was approximately 59,271 individuals. Door-to-door drug distribution, using dihydroartemisinin-piperaquine, was guided by satellite imagery-based mapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A mixed-methods evaluation was conducted to assess operational performance \u2014including acceptability, appropriateness, coverage, feasibility, fidelity, and adoption\u2014 using a community household survey (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009770), a health staff survey (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200928), and field observations (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009149).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among household survey participants eligible for medication during round 2, 96,2% (607\/631)\n                      <jats:italic>accepted<\/jats:italic>\n                      to participate in the pMDA. All health staff survey participants and 91,3% (703\/770) of household survey participants considered taking antimalarials while asymptomatic to be an acceptable preventive measure. All health staff survey participants (28\/28) and 84,1% (648\/770) of household survey participants felt the intervention was\n                      <jats:italic>appropriate<\/jats:italic>\n                      for reducing malaria transmission in the community. Programmatic or contact coverage (proportion of survey participants that received pMDA treatment) reached 73,9% (569\/770), while operational coverage (proportion of those present at the time of the intervention that received pMDA treatment) was 90,2% (569\/631). All health staff survey participants (28\/28) considered the pMDA implementation strategy\n                      <jats:italic>feasible<\/jats:italic>\n                      to implement. In terms of\n                      <jats:italic>fidelity<\/jats:italic>\n                      , direct observations of pMDA household visits showed that pMDA distribution teams correctly explained the purpose of the visit in 74,5% (111\/149) of interactions, requested verbal consent in 86,6% (129\/149), and emphasized the importance of completing the treatment in 60,4% (90\/149). Health staff survey participants showed strong willingness to\n                      <jats:italic>adopt<\/jats:italic>\n                      the procedures, with 86.0% (24\/28) and 96.0% (27\/28) expressing high commitment in rounds 1 and 2, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite the pMDA delivery strategy being implemented with good operational performance and being well accepted by the community and health staff, reaching the 80% coverage target remains challenging. Sustained collaboration and active engagement from communities, partners, and policymakers, and enhancement of some key outcomes, such as the fidelity of the implementation, are critical to improving coverage and ensuring the success of pMDA campaigns.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27035-7","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:16:02Z","timestamp":1775553362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Operational performance of a programmatic mass drug administration campaign for malaria in southern Mozambique: a comprehensive mixed-methods evaluation of implementation outcomes"],"prefix":"10.1186","volume":"26","author":[{"given":"Laura","family":"Fuente-Soro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tusell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amancio","family":"Nhangave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Bapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felisbela","family":"Materrula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9rcia","family":"Dimene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Sibindy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Candrinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Guinovart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"27035_CR1","unstructured":"World Health Organization. WHO guidelines for malaria. Geneva: WHO; 2025 https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria. Cited 9 Sep 2025."},{"key":"27035_CR2","doi-asserted-by":"crossref","unstructured":"Galatas B, Sa\u00fate F, Mart\u00ed-Soler H, Guinovart C, Nhamussua L, Simone W, et al. A multiphase program for malaria elimination in southern Mozambique (the Magude project): a before-after study. PLoS Med. 2020;17(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32797101\/. Cited 2025 Sep 9.","DOI":"10.1371\/journal.pmed.1003227"},{"key":"27035_CR3","doi-asserted-by":"crossref","unstructured":"Deng C, Wu W, Yuan Y, Li G, Zhang H, Zheng S, et al. Malaria control by mass drug administration with Artemisinin plus Piperaquine on Grande Comore Island, Union of Comoros. Open Forum Infect Dis. 2023;10(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36910690\/. Cited 2025 Sep 9.","DOI":"10.1093\/ofid\/ofad076"},{"issue":"8","key":"27035_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/infdis\/jiaa434","volume":"225","author":"M Fraser","year":"2022","unstructured":"Fraser M, Miller JM, Silumbe K, Hainsworth M, Mudenda M, Hamainza B, et al. Evaluating the impact of programmatic mass drug administration for malaria in Zambia using routine incidence data. J Infect Dis. 2022;225(8):1415\u201323. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32691047\/. Cited 2025 Sep 9.","journal-title":"J Infect Dis"},{"issue":"10133","key":"27035_CR5","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0140-6736(18)30792-X","volume":"391","author":"J Landier","year":"2018","unstructured":"Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, et al. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. Lancet. 2018;391(10133):1916\u201326. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29703425\/. Cited 2025 Sep 9.","journal-title":"Lancet"},{"issue":"11","key":"27035_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/cid\/ciy364","volume":"67","author":"C Deng","year":"2018","unstructured":"Deng C, Huang B, Wang Q, Wu W, Zheng S, Zhang H, et al. Large-scale Artemisinin-piperaquine mass drug administration with or without primaquine dramatically reduces malaria in a highly endemic region of Africa. Clin Infect Dis. 2018;67(11):1670\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29846536\/. Cited 2025 Sep 9.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"27035_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, Von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93(1):125\u201334. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4497884\/. Cited 2025 Sep 9.","journal-title":"Am J Trop Med Hyg"},{"key":"27035_CR8","unstructured":"World Health Organization. Mass drug administration for falciparum malaria: a practical field manual. 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241513104. Cited\u00a09 Sep 2025."},{"issue":"2","key":"27035_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2010","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2010;38(2):65. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3068522\/. Cited 2025 Sep 9.","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"27035_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):1\u201316. Available from: https:\/\/implementationscience.biomedcentral.com\/articles\/10.1186\/s13012-022-01245-0. Cited 2025 Sep 9.","journal-title":"Implement Sci"},{"issue":"2","key":"27035_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18929686\/. Cited 2025 Sep 9.","journal-title":"J Biomed Inform"},{"key":"27035_CR12","unstructured":"World Health Organization. World Health Organization vaccination coverage cluster surveys: reference manual. World Health Organization; 2018. https:\/\/www.who.int\/publications\/i\/item\/WHO-IVB-18.09."},{"key":"27035_CR13","doi-asserted-by":"crossref","unstructured":"Galatas B, Nhantumbo H, Soares R, Djive H, Murato I, Simone W, et al. Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: a mixed methods study. PLoS One. 2021;16(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33755685\/. Cited 2025 Sep 9.","DOI":"10.1371\/journal.pone.0249080"},{"issue":"1","key":"27035_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, Von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93(1):125\u201334. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26013371\/. Cited 2025 Sep 9.","journal-title":"Am J Trop Med Hyg"},{"key":"27035_CR15","doi-asserted-by":"crossref","unstructured":"Kuehne A, Tiffany A, Lasry E, Janssens M, Besse C, Okonta C, et al. Impact and lessons learned from mass drug administrations of malaria chemoprevention during the Ebola outbreak in Monrovia, Liberia, 2014. PLoS One. 2016;11(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27580098\/. Cited 2025 Sep 9.","DOI":"10.1371\/journal.pone.0161311"},{"issue":"6","key":"27035_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/trstmh\/try053","volume":"112","author":"TJ Peto","year":"2018","unstructured":"Peto TJ, Tripura R, Sanann N, Adhikari B, Callery J, Droogleever M, et al. The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study. Trans R Soc Trop Med Hyg. 2018;112(6):264. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6044409\/. Cited 2025 Sep 9.","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27035-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:34:57Z","timestamp":1781645697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27035-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27035"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27035-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Institutional Review Boards of the Hospital Cl\u00ednic of Barcelona (Spain) and the CISM. The purpose of both studies was explained to all participants, and written informed consent was obtained from all individuals included in both community and health staff surveys. This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki, including its most recent amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1602"}}